Literature DB >> 11087635

Adjuvant chemotherapy for stage II (Dukes' B) colon cancer: too early for routine use.

A Wein1, E G Hahn, S Merkel, W Hohenberger.   

Abstract

Entities:  

Mesh:

Year:  2000        PMID: 11087635     DOI: 10.1053/ejso.2000.0993

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


× No keyword cloud information.
  6 in total

1.  Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q.

Authors:  F Al-Mulla; S AlFadhli; A H Al-Hakim; J J Going; M S Bitar
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

2.  The impact of body mass index on oncological outcomes in colorectal cancer patients with curative intent.

Authors:  Yuji Toiyama; Junichiro Hiro; Tadanobu Shimura; Hiroyuki Fujikawa; Masaki Ohi; Koji Tanaka; Yasuhiro Inoue; Yasuhiko Mohri; Masato Kusunoki
Journal:  Int J Clin Oncol       Date:  2016-07-11       Impact factor: 3.402

3.  Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer.

Authors:  Yuji Toiyama; Chikao Miki; Yasuhiro Inoue; Koji Tanaka; Yasuhiko Mohri; Masato Kusunoki
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

4.  Circulating cell-free microRNAs as biomarkers for colorectal cancer.

Authors:  Yuji Toiyama; Koji Tanaka; Yasuhiro Inoue; Yasuhiko Mohri; Masato Kusunoki
Journal:  Surg Today       Date:  2015-02-25       Impact factor: 2.549

5.  Local recurrence after curative resection in patients with colon and rectal cancers.

Authors:  H R Yun; L J Lee; J H Park; Y K Cho; Y B Cho; W Y Lee; H C Kim; H K Chun; S H Yun
Journal:  Int J Colorectal Dis       Date:  2008-08-08       Impact factor: 2.571

6.  Prognostic relevance of tumour-associated macrophages and von Willebrand factor-positive microvessels in colorectal cancer.

Authors:  C Lackner; Z Jukic; O Tsybrovskyy; G Jatzko; V Wette; G Hoefler; M Klimpfinger; H Denk; K Zatloukal
Journal:  Virchows Arch       Date:  2004-06-30       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.